BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 1st Quarter - Termination Amendment

URL PHARMACEUTICALS

via IKON PUBLIC AFFAIRS

1st Quarter (Jan 1 - Mar 31) · 2012Posted Apr 20, 2012Filing document ↗LDA record ↗

Income$40Kfee reported

Client

Name: URL PHARMACEUTICALS
Description: drug pricing issues
Location: Pennsylvania · United States of America

Registrant

Firm: IKON PUBLIC AFFAIRS
Description: public affairs consulting
Location: Philadelphia, Pennsylvania, United States of America

Lobbying activities

1 issue

Pharmacy
drug pricing issues
LobbyistsCRAIG SNYDER · SCOTT HOEFLICH
Covered position (CRAIG SNYDER): Chief of Staff, Senator Arlen Specter 1998
Covered position (SCOTT HOEFLICH): Chief of Staff, Senator Arlen Specter 2006-2010
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

URL PHARMACEUTICALS — Lobbying — Receipts Report